Peptide Dosing Protocols

Stack Protocols

Peptide Stack Protocols: Multi-Compound Dosing Guides

Multi-peptide dosing guides with stack schedules, reconstitution math, and evidence backed research.

What Is Peptide Stacking?

Peptide stacking means using two or more peptide compounds together in a coordinated protocol. The idea is straightforward: each compound works through a different biological pathway, and combining them may produce complementary effects that a single peptide cannot achieve alone. A repair stack like the Wolverine (BPC-157 + TB-500) pairs a compound that works locally at injury sites with one that supports cell migration systemically. A weight management stack like CagriSema pairs two appetite-regulating pathways, amylin and GLP-1, for broader metabolic coverage.

Important context: No multi-peptide stack listed on this site has been evaluated as a combined protocol in a clinical trial. The synergy rationale for each stack is based on the individual evidence for each component compound, combined with community and practitioner usage patterns. Every stack page states this clearly in an evidence-level notice. For a broader introduction to stacking concepts, safety rules, and how to plan multi-compound protocols, see the Peptide Stacking 101 guide on PepPal.

Each stack protocol page on PDP follows a standardized format covering combined dosing schedules (separate vials, oral hybrid, and pre-blended formats where applicable), reconstitution math for every component, synergy rationale, side effects and safety, clinical evidence context per compound, storage guidelines, comparison to alternative stacks, and 12–14 answered FAQ questions.

Featured Suppliers

Peptide Partners P logo mark

Peptide Partners

Top PDP pick for Finnrick testing, quality, and value per mg.

View Verified Peptides
Orbitrex logo

Orbitrex Peptides

Strong for single-vial buying and broader compound selection.

View Verified Peptides

Browse Stacks by Goal

Tissue Repair & Recovery Stacks

These stacks combine repair-focused peptides that target different layers of the healing process, from vascular support and cell migration to tissue remodeling and inflammation control. The Wolverine Stack is the simplest starting point. GLOW and KLOW add skin-quality and anti-inflammatory layers.

  • Wolverine Stack: BPC-157 + TB-500

    2 compounds · Localized repair + systemic cell migration

    The most widely discussed repair combination in the peptide community. Loading + maintenance phases. SubQ injection.

  • GLOW Stack: BPC-157 + TB-500 + GHK-Cu

    3 compounds · Wolverine foundation + skin remodeling

    Adds copper peptide for collagen support, wound healing, and gene expression modulation. Pre-blended vials available.

  • KLOW Stack: BPC-157 + TB-500 + GHK-Cu + KPV

    4 compounds · GLOW foundation + anti-inflammatory control

    Adds KPV (alpha-MSH tripeptide) for NF-kB pathway modulation. The most comprehensive repair stack on PDP.

Weight Management & Metabolic Stacks

These stacks pair appetite-regulating compounds that work through complementary pathways: amylin signaling, GLP-1 receptor agonism, GIP agonism, and glucagon activation. All components in these stacks have published human clinical trial data individually.

  • CagriSema Stack: Cagrilintide + Semaglutide

    2 compounds · Amylin analog + GLP-1 agonist

    Novo Nordisk's Phase 3 combination. REDEFINE 1 trial data available. Fixed-dose combination in development.

  • Cagrilintide + Tirzepatide: Cagrilintide + Tirzepatide

    2 compounds · Amylin analog + dual GIP/GLP-1 agonist

    Community-derived combination pairing amylin with the highest-efficacy dual agonist.

  • Cagrilintide + Retatrutide: Cagrilintide + Retatrutide

    2 compounds · Amylin analog + triple agonist (GLP-1/GIP/glucagon)

    Pairs amylin with the broadest receptor coverage in the incretin class.

Growth Hormone Optimization Stacks

The "push-pull" model: a GHRH analog stimulates GH production while a GHRP amplifies pulse frequency. This pairing is the most established peptide stacking pattern, supported by studies showing GH elevation greater than either compound alone.

  • CJC-1295 (no DAC) + Ipamorelin GH Pulse Stack: CJC-1295 (no DAC) + Ipamorelin

    2 compounds · GHRH analog + selective GHRP

    Timed 2–3x daily on empty stomach. Most popular GH-optimizing stack. Minimal cortisol and prolactin elevation.

Body Recomposition Stacks

Multi-goal stacks combining GH optimization with metabolic and repair support for simultaneous muscle preservation and fat loss.

  • Advanced Recomp Stack: Multi-compound

    3+ compounds · GH optimization + metabolic support + recovery

    The most complex protocol on PDP. Designed for experienced users with multiple concurrent goals.

Cognitive & Nootropic Stacks

  • Russian Nootropic Stack: Selank + Semax

    2 compounds · Anxiolytic (Selank) + cognitive support (Semax)

    Both compounds approved as pharmaceuticals in Russia. Intranasal and SubQ routes covered.

Which Stack Is Right for Your Goal?

If you are not sure where to start, this table maps common goals to the most relevant stack protocol.

Your GoalRecommended StackComponentsComplexity
Injury recovery (tendon, ligament, muscle)Wolverine StackBPC-157 + TB-500Low: 2 compounds
Injury recovery + skin qualityGLOW StackBPC-157 + TB-500 + GHK-CuMedium: 3 compounds
Recovery + inflammation controlKLOW StackBPC-157 + TB-500 + GHK-Cu + KPVHigher: 4 compounds
Weight loss (clinical-grade)CagriSemaCagrilintide + SemaglutideLow: 2 compounds
Weight loss (maximum receptor coverage)Cagrilintide + RetatrutideCagrilintide + RetatrutideLow: 2 compounds
Growth hormone optimizationCJC-1295 + IpamorelinCJC-1295 (no DAC) + IpamorelinMedium: timed dosing
Cognitive focus + calmRussian Nootropic StackSelank + SemaxLow: 2 compounds, intranasal
Body recomposition (advanced)Advanced Recomp StackMulti-compoundHigher: 3+ compounds

Start with a 2-compound stack before moving to more complex combinations. Each individual compound should ideally be run solo first to gauge your response before adding it to a stack. For stacking safety fundamentals, read Peptide Stacking 101.

Recently Updated

  • April 2026: KLOW Stack: Updated KPV evidence section and oral dosing notes
  • March 2026: Wolverine Stack: Updated BPC-157 and TB-500 regulatory status following FDA Category 1 reclassification
  • March 2026: GLOW Stack: Updated GHK-Cu stability data and pre-blend assessment

All stack protocols carry a “Last reviewed” date. We update stack pages when component compound data changes, regulatory status shifts, or reconstitution math needs correction.

Directory

A-Z Stack Directory

Filter the full research index by letter to jump directly into published peptide stacks.

9 indexed entries

A

1 entries

C

4 entries

G

1 entries

K

1 entries

R

1 entries

W

1 entries

Frequently Asked Questions: Peptide Stack Protocols

What is a peptide stack?

A peptide stack is a combination of two or more peptide compounds used together in a coordinated dosing protocol. Each compound targets a different biological pathway, and the combination aims to produce complementary effects. For example, the Wolverine Stack pairs BPC-157 (local tissue repair) with TB-500 (systemic cell migration) for broader recovery coverage than either compound alone.

How many stack protocols does PDP publish?

PDP currently publishes 9 named stack protocols covering tissue repair, weight management, growth hormone optimization, body recomposition, and cognitive support. Each stack page follows a standardized format with combined dosing schedules, reconstitution math for all components, synergy rationale, side effects, clinical evidence context per compound, and 12–14 answered FAQs.

Have any of these stacks been tested in clinical trials?

Only the CagriSema stack (cagrilintide + semaglutide) has been evaluated as a combined protocol in clinical trials through the Novo Nordisk REDEFINE program. All other stacks on PDP are community-derived combinations based on the individual evidence for each component compound. Every stack page states this in an evidence-level notice at the top of the dosing section. We never present community protocols as clinical fact.

What is the difference between the Wolverine, GLOW, and KLOW stacks?

These three stacks form a progression. The Wolverine Stack is the base: BPC-157 + TB-500 for tissue repair. The GLOW Stack adds GHK-Cu (copper peptide) for skin remodeling and gene expression support. The KLOW Stack adds KPV (anti-inflammatory tripeptide) on top of GLOW for inflammatory-environment control. Start with Wolverine if your primary goal is injury recovery, then step up if you want skin-quality or anti-inflammatory coverage.

How do I reconstitute a multi-compound stack?

Each component in a stack is reconstituted separately in its own vial using bacteriostatic water, following the same 7-step reconstitution process used for any single peptide. Some stacks also have pre-blended vials available. The stack page covers both formats when applicable. For custom vial sizes and water volumes, use the PepPal Reconstitution Calculator. Reconstitution tables on each stack page show the math for all common vial sizes.

Should I start with a stack or a single peptide?

Start with a single compound. Running one peptide first lets you gauge your response, identify any side effects, and confirm proper reconstitution and injection technique before adding complexity. Once you are comfortable with individual compounds, you can combine them into a stack. For guidance on building your first stack, read Peptide Stacking 101.

How long should I run a stack?

Cycle length depends on the specific stack. Repair stacks (Wolverine, GLOW, KLOW) typically run 4–8 weeks with a 2–4 week off period. Weight management stacks follow longer titration schedules matching their component compounds' clinical trial protocols. GH stacks often run 8–12 weeks with periodic off-cycles to prevent receptor desensitization. Each stack page includes a cycle guidelines table with recommended durations.

Where do I find dosing for each compound in a stack?

Each stack page includes a combined dosing table showing every compound's dose, frequency, route, and phase. For deeper detail on any individual compound, including mechanism of action, full side effect profile, or clinical trial data, follow the link to that compound's individual protocol page. Stack pages always link to all component protocol pages.

How do the weight management stacks compare?

PDP covers three weight management stacks: CagriSema (cagrilintide + semaglutide), Cagrilintide + Tirzepatide, and Cagrilintide + Retatrutide. All three pair cagrilintide (amylin analog) with a different incretin compound. CagriSema has Phase 3 clinical trial data. The tirzepatide and retatrutide combinations are community-derived. Each stack page includes a comparison table showing receptor coverage, efficacy data, and regulatory status.

Is this medical advice?

No. Peptide Dosing Protocols is an independent educational reference database. No stack or combination listed is recommended, prescribed, or endorsed for human use. All combined dosing information is compiled from published research and community protocols for educational purposes only. Consult a licensed healthcare provider before considering any compound or combination.

Request Next Coverage

Don't see a dosing guide for your peptide or stack? Request it.

Send the compound or stack you want researched next. These requests help prioritize upcoming protocol coverage, especially for compounds that are moving from forum chatter into active research demand.

Emerging GLP-1 combinations
Lesser-known repair compounds
Custom stack demand signals

For Research & Educational Purposes Only

Peptide Partners